Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity.

Biotechnology

Health & Wellness

Aurinia Pharmaceuticals

The Edmonton office focuses on quality assurance and operational excellence for regional projects and initiatives.

Edmonton

Aurinia Pharmaceuticals' headquarters in Victoria, Canada

Peter Greenleaf

Ron Flauto

Archie Stone

Henry Leher

Ernie Yap M.D.

Michael Gammons

Lucy Alexis Shieh Sphr

Prem Ramiya

Ryan Cole

Nicole Wood

Richard Lewis

Kerry Tremayne

Eric Turowski

Max Donley

Tim Hermes

Sue Rogers

Ann M. Daus

Eric Victory

Cecilia Matthews

Joe Miller

Stephen Robertson

Volker Knappertz

Daniel G. Billen

Jill Leversage

Daniel Billen

David R.W. Jayne

R. Hector MacKay-Dunn

Thomas Dorner

Laura Carter

Alvin F. Wells

Peter Kiener

Hans-Peter Hartung

This department focuses on sales and specialist roles related to immunology and rare diseases.

Immunology Division

The Sales and Market Access team at Aurinia Pharmaceuticals is responsible for developing and implementing strategies that ensure market entry and accessibility for the company’s products in the nephrology and autoimmunity sectors. This team collaborates with healthcare providers, payers, and stakeholders to optimize pricing, reimbursement, and strategic partnerships, all while driving sales growth and fostering strong relationships in the healthcare ecosystem. Their efforts are essential in translating clinical advancements into accessible and impactful treatments for patients.

Sales and Market Access

The Clinical Operations and Research team at Aurinia Pharmaceuticals is responsible for overseeing the planning, execution, and management of clinical trials related to nephrology and autoimmunity therapies. This multidisciplinary team, which includes senior leaders and medical science liaisons, collaborates to ensure compliance with regulatory standards, optimize patient recruitment, and analyze data to support the development of innovative treatments. Their efforts are crucial for advancing clinical knowledge and bringing new therapies to market.

Clinical Operations and Research

This department is responsible for strategic direction and overall management of organizational initiatives.

Leadership Oversight

The Leadership Team at Aurinia Pharmaceuticals is responsible for guiding the strategic vision and operational direction of the company, focusing on the development and commercialization of innovative therapies for nephrology and autoimmunity. Composed of key executives, including the CEO, CFO, and Chief Business Officer, the team collaborates to ensure regulatory compliance, drive business growth, and oversee quality assurance initiatives, all while fostering a culture of excellence and integrity within the organization.

Leadership Team

The Manufacturing and Quality team at Aurinia Pharmaceuticals is responsible for overseeing the production and quality assurance of biopharmaceutical products, ensuring they meet regulatory standards and clinical requirements. This team collaborates closely with supply chain and procurement to optimize manufacturing processes, maintain high quality standards, and support the development of innovative therapies in nephrology and autoimmunity. Their focus is on delivering safe, effective products while ensuring compliance with industry regulations.

Manufacturing and Quality

Aurinia Pharmaceuticals

Org chart

Board & advisors

Teams

Immunology Division

Sales and Market Access

Clinical Operations and Research

Leadership Oversight

Leadership Team

Manufacturing and Quality

Offices

Aurinia Pharmaceuticals

Org chart

Board & advisors

Teams

Immunology Division

Sales and Market Access

Clinical Operations and Research

Leadership Oversight

Leadership Team

Manufacturing and Quality

Offices

Related companies